The 170-acre northeast-side Indianapolis campus is composed of 21 buildings and serves as one of the company’s two global hubs.
Read More
The health system received approval from the U.S. Food and Drug Administration in January for the IU Health 3D Print Studio.
Read More
In October, Corteva’s board of directors unanimously approved a plan to separate the company into two independent, publicly traded businesses.
The funding commitment from Telamon Corp. CEO Stanley Chen and his wife, Allison, will be doubled to $2 million by a dollar-by-dollar match by IU Health.
Elanco Animal Health Inc. is among the companies taking a leading role in combating the re-emergence of deadly New World screwworm that was pushed out of the United States six decades ago.
The move to remove Meridian from Anthem’s Medicaid network will take effect July 25 and impact about 18,000 patients.
Stat reported that Lilly and the FDA allowed a 79-year-old man to gain access to the retatrutide through the FDA’s compassionate use program.
The Medicare GLP-1 Bridge program is designed to provide temporary access to GLP-1 obesity drugs while federal officials examine longer-term approaches to obesity treatment through Medicare.
The topic is being addressed both within hospitals and in state legislatures.
Negotiations continue as a deadline looms, but disagreements persist about the reimbursement rate Ascension St. Vincent should receive for care provided to UnitedHealthcare members.
The program will target investments in animal-health therapeutics and technologies but could also support other life sciences startups.
The grant from the National Institutes of Health will allow researchers from the IU School of Medicine and the IU Luddy School of Informatics, Computing and Engineering to accelerate the search for new Alzheimer’s treatments.
No athlete wants to endure a torn knee ligament. But for OrthoIndy CEO Dr. Matthew Lavery, an injury playing football for Division III Millikin University sparked an interest in fixing other people’s injuries.
The procedure allows surgeons to make smaller incisions than are typically made in traditional mastectomies.
Former Chief Execution Officer Shane Hochradel resigned from Elevance in May and joined California-based Alignment Healthcare on June 1.
In January, the Centers for Medicare & Medicaid Services, or CMS, removed 285 procedures — mostly musculoskeletal, like revision hip and knee replacements — from its Medicare Inpatient-Only list.
Trial patients who received the drug after surgery or radiation therapy experienced an 83% reduction in the risk of disease recurrence or death compared with those who received a placebo.
The organization has already raised $3.9 million for its campaign with gifts from Eli Lilly and Co. Foundation, United Way of Central Indiana and other groups.
BE-101, soon to be known as Optavant, is expected to be commercially available in the third quarter of this year after it receives full licensure from the U.S. Department of Agriculture.
Rural hospitals in Indiana are facing a crisis that could lead to more health deserts across the state, hospital leaders say.
Dr. Scott D. Boden will succeed Dr. Jay Hess, one of the longest-serving medical school deans in the country.
CVS Caremark will add Foundayo coverage on June 1 and resume covering Zepbound on Oct. 1.
